[1]高 鹏,高 浩,燕 飞.坏疽性脓皮病1例[J].医学信息,2019,32(01):191-192.[doi:10.3969/j.issn.1006-1959.2019.01.063]
点击复制

坏疽性脓皮病1例()
分享到:

医学信息[ISSN:1006-1959/CN:61-1278/R]

卷:
32卷
期数:
2019年01期
页码:
191-192
栏目:
出版日期:
2019-01-01

文章信息/Info

文章编号:
1006-1959(2019)01-0191-02
作者:
高 鹏1高 浩2燕 飞1
1.青岛大学附属威海市立二院皮肤科,山东 威海 264200;2.威海市立医院,山东 威海 264200
关键词:
坏疽性脓皮病糖皮质激素免疫抑制剂
分类号:
R753.6
DOI:
10.3969/j.issn.1006-1959.2019.01.063
文献标志码:
B

参考文献/References:

[1]赵辨.中国临床皮肤病学[M].南京:江苏科学技术出版社,2010:892-894.
[2]Su WP,Davis MD,Weening RH,et al.Pyoderma gangrenosum:clinicopathologic correlation and proposed diagnostic criteria[J].Int J Dermatol,2004,43(11):790-800.
[3]田洪青.坏疽性脓皮病的治疗进展[J].中国麻风皮肤病杂志,2005,21(7):541-543.

相似文献/References:

[1]钟时嘉.亚急性甲状腺炎的临床分析[J].医学信息,2018,31(01):181.[doi:10.3969/j.issn.1006-1959.2018.01.073]
 ZHONG Shi-jia.Clinical Analysis of Subacute Thyroiditis[J].Journal of Medical Information,2018,31(01):181.[doi:10.3969/j.issn.1006-1959.2018.01.073]
[2]唐培渊,宋俊峰,秦克乐,等.难治性特发性血小板减少性紫癜的治疗进展[J].医学信息,2018,31(05):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
 TANG Pei-yuan,SONG Jun-feng,QIN Ke-le,et al.Progress in Treatment of Refractory Idiopathic Thrombocytopenic Purpura[J].Journal of Medical Information,2018,31(01):42.[doi:10.3969/j.issn.1006-1959.2018.05.016]
[3]苗艳茹.甲巯咪唑与糖皮质激素联合治疗甲状腺功能亢进症合并症的效果分析[J].医学信息,2018,31(05):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
 MIAO Yan-ru.Analysis of Effects of Methimazole and Glucocorticoids on Complications of Hyperthyroidism[J].Journal of Medical Information,2018,31(01):136.[doi:10.3969/j.issn.1006-1959.2018.05.048]
[4]康 凯,郑继伟,王 闰.糖皮质激素治疗甲亢伴浸润性突眼的疗效分析[J].医学信息,2018,31(08):103.[doi:10.3969/j.issn.1006-1959.2018.08.033]
 KANG Kai,ZHENG Ji-wei,WANG Run.Efficacy of Glucocorticoids in the Treatment of Hyperthyroidism with Infiltrating Exophthalmos[J].Journal of Medical Information,2018,31(01):103.[doi:10.3969/j.issn.1006-1959.2018.08.033]
[5]赵 维,廖荣宏,王爱华.糖皮质激素治疗心力衰竭疗效与安全性的Meta分析[J].医学信息,2018,31(14):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
 ZHAO Wei,LIAO Rong-hong,WANG Ai-hua.Meta-analysis of the Efficacy and Safety of Glucocorticoids in the Treatment of Heart Failure[J].Journal of Medical Information,2018,31(01):70.[doi:10.3969/j.issn.1006-1959.2018.14.021]
[6]刘广涛,关凤军,董 晨.原发性肾病综合征患儿肾组织P-gp170蛋白和mRNA表达与临床病理及预后的关系[J].医学信息,2018,31(21):61.[doi:10.3969/j.issn.1006-1959.2018.21.017]
 LIU Guang-tao,GUAN Feng-jun,DONG Chen.Relationship between the Expression of p-gp170 Protein and mRNA in Renal Tissue of Children with Primary Nephrotic Syndrome and Clinical Pathology and Prognosis[J].Journal of Medical Information,2018,31(01):61.[doi:10.3969/j.issn.1006-1959.2018.21.017]
[7]陈晓霞,唐 勇,胡 庆,等.吗替麦考酚酯联合糖皮质激素治疗特发性膜性肾病的疗效观察[J].医学信息,2018,31(22):89.[doi:10.3969/j.issn.1006-1959.2018.22.024]
 CHEN Xiao-xia,TANG Yong,HU Qing,et al.Therapeutic Effect of Mycophenolate Mofetil Combined with Glucocorticoid on Idiopathic Membranous Nephropathy[J].Journal of Medical Information,2018,31(01):89.[doi:10.3969/j.issn.1006-1959.2018.22.024]
[8]马艳艳,刘建军.肌无力危象的治疗研究进展[J].医学信息,2019,32(06):45.[doi:10.3969/j.issn.1006-1959.2019.06.016]
 MA Yan-yan,LIU Jian-jun.Progress in the Treatment of Myasthenia Crisis[J].Journal of Medical Information,2019,32(01):45.[doi:10.3969/j.issn.1006-1959.2019.06.016]
[9]谢卫强,巩 栋,高明暄,等.关节病性银屑病伴髋关节结核1例[J].医学信息,2019,32(07):189.[doi:10.3969/j.issn.1006-1959.2019.07.062]
[10]王立英.糖皮质激素治疗突发性聋的研究[J].医学信息,2019,32(11):52.[doi:10.3969/j.issn.1006-1959.2019.11.015]
 WANG Li-ying.Glucocorticoid Therapy for Sudden Deafness[J].Journal of Medical Information,2019,32(01):52.[doi:10.3969/j.issn.1006-1959.2019.11.015]

更新日期/Last Update: 2019-01-22